Glycosylated hemoglobin a1 predicts risk for symptomatic hemorrhage after thrombolysis for acute stroke

Stroke

Volumn 44, Issue 8, 2013, Pages 2134-2138

  Rocco, Andrea ^a,d   Heuschmann, Peter U ^b   Schellinger, Peter D ^c   Köhrmann, Martin ^d   Diedler, Jennifer ^a   Sykora, Marek ^a   Nolte, Christian H ^d   Ringleb, Peter ^a   Hacke, Werner ^a   Jüttler, Eric ^a,d,e  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c KLINIKUM MINDEN   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF ULM   (Germany)

Author keywords

acute stroke; blood glucose; glycosylated hemoglobin; outcome; symptomatic hemorrhage; thrombolytic therapy; tissue plasminogen activator

Indexed keywords

ALTEPLASE; HEMOGLOBIN A1C;

AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYMPTOMATIC INTRACEREBRAL HEMORRHAGE; TREATMENT OUTCOME;

ACUTE STROKE; BLOOD GLUCOSE; GLYCOSYLATED HEMOGLOBIN; OUTCOME; SYMPTOMATIC HEMORRHAGE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

AGED; AGED, 80 AND OVER; CEREBRAL HEMORRHAGE; FEMALE; FIBRINOLYTIC AGENTS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84880794685     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.675918     Document Type: Article

References (28)

1. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(suppl 3):483S-512S. (Pubitemid 39297962)
2. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? Neurology. 2001;56:1015-1020.
3. Lindsberg PJ, Kaste M. Thrombolysis for ischemic stroke. Curr Opin Neurol. 2003;16:73-80.
4. Demchuk AM, Morgenstern LB, Krieger DW, Linda Chi T, Hu W, Wein TH, et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke. 1999;30:34-39. (Pubitemid 29029438)
5. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affrms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38:1655-1711. (Pubitemid 46691097)
6. del Zoppo GJ, von Kummer R, Hamann GF. Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry. 1998;65:1-9. (Pubitemid 28302350)
7. Alex M, Baron EK, Goldenberg S, Blumenthal HT. An autopsy study of cerebrovascular accident in diabetes mellitus. Circulation. 1962;25:663-673.
8. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-412. (Pubitemid 30609442)
9. Danne T, Weber B, Dinesen B, Mortensen HB. Threshold of HbA1c for the effect of hyperglycemia on the risk of diabetic microangiopathy. Diabetes Care. 1996;19:183.
10. Mazya M, Egido JA, Ford GA, Lees KR, Mikulik R, Toni D, et al. Predicting the risk of symptomatic intracerebral hemorrhage in isch-emic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke. 2012;43:1524-31.
11. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
12. Gray CS, Scott JF, French JM, Alberti KG, O'Connell JE. Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke. Age Ageing. 2004;33:71-77. (Pubitemid 38111452)
13. Oppenheimer SM, Hoffbrand BI, Oswald GA, Yudkin JS. Diabetes mel-litus and early mortality from stroke. Am J Med. 1995;74:540-544.
14. Bruno A, Biller J, Adams HP Jr, Clarke WR, Woolson RF, Williams LS, et al. Acute blood glucose level and outcome from ischemic stroke. Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Neurology. 1999;52:280-284.
15. Allport LE, Butcher KS, Baird TA, MacGregor L, Desmond PM, Tress BM, et al. Insular cortical ischemia is independently associated with acute stress hyperglycemia. Stroke. 2004;35:1886-1891. (Pubitemid 38971870)
16. Gray CS, Hildreth AJ, Alberti GK, ÓConnell JE. Poststroke hyperglyce-mia: natural history and immediate management. Stroke. 2004;35:122-126. (Pubitemid 38057604)
17. Ginsberg MD, Prado R, Dietrich WD, Busto R, Watson BD. Hyperglycemia reduces the extent of cerebral infarction in rats. Stroke. 1987;18:570-574. (Pubitemid 17080569)
18. Kawai N, Keep RF, Betz AL. Hyperglycemia and the vascular effects of cerebral ischemia. Stroke. 1997;28:149-154. (Pubitemid 27039479)
19. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyper-glycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426-2432. (Pubitemid 32954818)
20. Paciaroni M, Agnelli G, Caso V, Corea F, Ageno W, Alberti A, et al. Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke. Cerebrovasc Dis. 2009;28:119-123.
21. Alvarez-Sabín J, Molina CA, Montaner J, Arenillas JF, Huertas R, Ribo M, et al. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator-treated patients. Stroke. 2003;34:1235-1241.
22. Nordt TK, Klassen KJ, Schneider DJ, Sobel BE. Augmentation of synthesis of plasminogen activator inhibitor type-1 in arterial endothelial cells by glucose and its implications for local fbrinolysis. Arterioscler Thromb. 1993;13:1822-1828. (Pubitemid 23360569)
23. Broderick JP, Hagen T, Brott T, Tomsick T. Hyperglycemia and hemor-rhagic transformation of cerebral infarcts. Stroke. 1995;26:282-287.
24. Aso Y, Inukai T, Tayama K, Takemura Y. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes. Acta Diabetol. 2000;37:87-92. (Pubitemid 32009315)
25. Derex L, Nighoghossian N. Intracerebral haemorrhage after thromboly-sis for acute ischaemic stroke: an update. J Neurol Neurosurg Psychiatry. 2008;79:1093-1099.
26. Ribo M, Molina C, Montaner J, Rubiera M, Delgado-Mederos R, Arenillas JF, et al. Acute hyperglycemia state is associated with lower tPA-induced recanalization rates in stroke patients. Stroke. 2005;36:1705-1709. (Pubitemid 41098766)
27. Putaala J, Sairanen T, Meretoja A, Lindsberg PJ, Tiainen M, Liebkind R, et al. Post-thrombolytic hyperglycemia and 3-month outcome in acute ischemic stroke. Cerebrovasc Dis. 2011;31:83-92.
28. Kamouchi M, Matsuki T, Hata J, Kuwashiro T, Ago T, Sambongi Y, et al. Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: the Fukuoka Stroke Registry. Stroke. 2011;42:2788-94.